Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Utopia SIS SpA is an investment company based in Italy, established to invest in high-growth projects within the Life Sciences sector. Founded to address the significant gap in venture capital investments in Italy compared to other European countries, Utopia aims to support startups that contribute to collective well-being across the value chain.
The firm currently manages a portfolio of six companies and focuses on Seed and Series A investments. Utopia SIS SpA emphasizes scientific merit and innovative solutions in healthcare, positioning itself as a key player in the Italian venture capital landscape.
With a dedicated team of professionals, Utopia SIS SpA is committed to fostering growth in the Life Sciences sector, particularly in biotech and healthcare. The firm operates from its headquarters in Italy and primarily targets European markets.
Utopia SIS SpA invests primarily in Seed and Series A stages within the Life Sciences sector. Their investment focus includes Disease Modifying Drugs, Medical Devices, Diagnostic Tools and Biomarkers, and Cross-border applications of Artificial Intelligence in healthcare. The organization seeks innovative projects that develop potential therapies for unmet medical needs.
Utopia emphasizes the scientific merit of the companies they evaluate, looking for startups that can demonstrate a clear path to addressing significant healthcare challenges. The firm is particularly interested in projects that can contribute to collective well-being, aligning with their mission to enhance health outcomes through scientific advancements.
Utopia SIS SpA's portfolio includes six notable companies that are engaged in various aspects of the medical and scientific ecosystem. These companies are:
These companies are selected for their high-growth potential and their contributions to the Life Sciences sector, particularly in addressing unmet medical needs.
Antonio Falcone - Chief Executive Officer. Antonio has extensive experience in venture capital and investment management, focusing on the Life Sciences sector.
Sergio Abrignani - Scientific Venture Partner. Sergio brings a wealth of knowledge in biotechnology and healthcare, having led numerous successful projects in the field.
Rodolfo Quagliuolo - Risk Manager. Rodolfo specializes in assessing investment risks and ensuring the sustainability of portfolio companies.
Emanuele D'Erme - Financial Analyst. Emanuele has a strong background in financial analysis and investment strategy, contributing to the firm's decision-making processes.
To pitch to Utopia SIS SpA, founders should use the contact email info@utopiasis.it. A well-structured pitch deck that includes the business model, market analysis, and scientific validation is essential. Response times may vary, but founders can expect feedback within a few weeks.
As of October 2023, Utopia SIS SpA continues to expand its portfolio in the Life Sciences sector, focusing on innovative startups that address unmet medical needs. The firm has recently engaged with several new companies in the biotech space, enhancing its investment strategy.
Utopia SIS SpA remains committed to filling the venture capital gap in Italy, actively seeking partnerships with startups that align with their mission of promoting collective well-being through scientific advancements.
What are Utopia SIS SpA's investment criteria?
Utopia SIS SpA invests in Seed and Series A stages, focusing on innovative startups in the Life Sciences sector. They prioritize projects that address unmet medical needs and demonstrate scientific merit.
How can I apply or pitch to Utopia SIS SpA?
Founders can pitch their ideas through the contact email provided on their website, which is info@utopiasis.it. A detailed pitch deck outlining the business model, market opportunity, and scientific basis is recommended.
What makes Utopia SIS SpA different from other investors?
Utopia SIS SpA specifically targets the Life Sciences sector in Italy, addressing a significant gap in venture capital investments. Their focus on scientific merit and collective well-being sets them apart from other firms.
What is the geographic scope of Utopia SIS SpA's investments?
The firm primarily invests in startups located in Europe, with a strong emphasis on projects based in Italy.
What is Utopia SIS SpA's post-investment involvement?
Utopia SIS SpA actively supports its portfolio companies through mentorship and strategic guidance, leveraging their expertise in the Life Sciences sector to help startups grow.
What is the typical check size for investments?
While specific check sizes are not disclosed, Utopia SIS SpA focuses on Seed and Series A investments, which typically range from several hundred thousand to a few million euros.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.